Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Malone › NPI 1568735660
Physician

Alice Hyde Medical Center

Alice Hyde Medical Center was paid $22.41M by Medicaid between Jan 2018 and Dec 2024, across 264 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 24% of everything it billed.

33Billing provider infoALICE HYDE MEDICAL CENTER
MALONE, NY 12953
33aNPI1568735660assigned 02/21/2012
33bProvider typeDermatology Physician
28Total paid$22.41M
24GClaims471,463
24DCodes billed264
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Dermatology Physician providers in New York

Rank by total paid#3 of 349
Median peer was paid$26K
This provider vs. median878×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201810,794$541K
201928,964$1.17M
202082,879$3.28M
2021104,000$4.31M
202286,160$5.66M
202385,809$4.26M
2024incomplete72,857$3.18M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 24% 48,591 43,616 $5.37M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 9.9% 18,925 17,783 $2.22M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 5.3% 8,288 7,798 $1.19M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 4.2% 12,884 11,375 $934K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 3.5% 6,218 5,992 $775K
80053 Comprehensive metabolic panel 2.8% 24,948 22,777 $638K
97530 Therapeutic activities, direct patient contact, each 15 minutes 2.8% 6,217 1,736 $633K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.5% 5,209 1,634 $559K
96361 Intravenous infusion, hydration; each additional hour 2.2% 2,406 2,275 $497K
36415 Collection of venous blood by venipuncture 2.1% 20,532 17,517 $472K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.8% 1,622 1,583 $392K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 1.7% 3,880 3,748 $377K
252 more codes
70450 Computed tomography, head or brain; without contrast material 1.6% 1,297 $365K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 1.6% 2,836 $357K
99285 Emergency room visit (most serious) 1.5% 2,663 $325K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.4% 2,170 $317K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 1.4% 2,733 $303K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1.3% 2,315 $298K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1.3% 9,542 $294K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 1.3% 2,616 $285K
99442 1.3% 2,385 $283K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 1.2% 2,345 $266K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 1.1% 2,075 $251K
20610 1.0% 955 $230K
99215 Doctor's office visit, returning patient (complex) <1% 1,651 $221K
87631 <1% 1,791 $220K
51798 <1% 728 $206K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 1,558 $193K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 1,901 $193K
99203 Doctor's office visit, new patient (routine) <1% 1,620 $186K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 5,990 $180K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 9,873 $148K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,552 $145K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 612 $115K
G2025 Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only <1% 1,493 $114K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 440 $113K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,646 $107K
81025 <1% 3,088 $105K
80061 Lipid panel <1% 13,001 $105K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 598 $103K
93976 <1% 372 $102K
84443 Thyroid stimulating hormone (TSH) <1% 12,217 $100K
99441 <1% 940 $92K
36416 <1% 1,131 $84K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,947 $83K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 2,353 $80K
96127 <1% 4,199 $77K
83036 Hemoglobin; glycosylated (A1C) <1% 9,559 $73K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,929 $71K
99406 <1% 3,239 $67K
97161 <1% 646 $63K
80048 Basic metabolic panel (calcium, ionized) <1% 3,393 $62K
99204 Doctor's office visit, new patient (more involved) <1% 534 $62K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,674 $53K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 24,395 $53K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 353 $51K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 323 $43K
90686 <1% 1,220 $43K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,873 $43K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 928 $36K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 290 $35K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 919 $33K
90715 <1% 1,411 $32K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 3,705 $31K
82607 <1% 2,466 $28K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 129 $28K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 810 $27K
97016 <1% 587 $27K
83880 <1% 979 $26K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 664 $25K
84153 <1% 1,644 $25K
86850 <1% 537 $22K
81003 <1% 6,522 $21K
82728 <1% 2,179 $21K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 400 $21K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 593 $18K
84439 <1% 2,271 $18K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 530 $18K
87086 Culture, bacterial; quantitative colony count, urine <1% 6,660 $18K
59025 Fetal non-stress test <1% 102 $17K
90670 <1% 773 $17K
99443 <1% 161 $15K
86901 <1% 626 $15K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 1,361 $14K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 483 $14K
83655 <1% 1,051 $13K
90723 <1% 596 $12K
88142 <1% 423 $11K
90647 <1% 547 $11K
86900 <1% 626 $11K
G0378 Hospital observation service, per hour <1% 392 $11K
93017 <1% 131 $10K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 24 $10K
71046 Radiologic examination, chest; 2 views <1% 3,540 $10K
82803 <1% 578 $10K
85027 <1% 3,507 $9K
90734 <1% 390 $9K
71250 <1% 92 $9K
97162 <1% 71 $8K
84702 <1% 1,297 $8K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 2,195 $8K
0352U <1% 202 $8K
82570 <1% 1,882 $8K
84481 <1% 910 $8K
90688 <1% 313 $8K
83540 <1% 1,991 $7K
82043 <1% 1,529 $7K
87632 <1% 330 $7K
87077 <1% 1,953 $7K
87070 <1% 2,955 $7K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 108 $7K
88174 <1% 252 $7K
90651 <1% 156 $6K
83550 <1% 1,702 $6K
81001 <1% 5,004 $6K
85610 <1% 2,333 $6K
0012A <1% 141 $6K
90710 <1% 265 $6K
84207 <1% 200 $5K
87186 <1% 1,925 $5K
76770 <1% 28 $5K
90671 <1% 198 $5K
76830 Ultrasound, transvaginal <1% 218 $5K
12001 <1% 12 $5K
93000 <1% 2,274 $5K
99385 <1% 39 $5K
Q2038 Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) <1% 217 $4K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 3,814 $4K
83735 <1% 3,062 $4K
86618 <1% 331 $4K
86803 <1% 604 $4K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 3,004 $3K
90661 <1% 134 $3K
86140 <1% 1,352 $3K
76536 <1% 142 $3K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 27 $3K
96367 <1% 94 $3K
71271 <1% 31 $2K
80076 <1% 153 $2K
73030 <1% 757 $2K
99233 Hospital visit by a doctor, follow-up day (complex) <1% 19 $2K
83690 <1% 3,828 $2K
90633 <1% 86 $2K
73630 <1% 741 $2K
72100 <1% 251 $2K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 13 $2K
99239 Hospital discharge day management, more than 30 minutes <1% 14 $1K
87340 <1% 308 $1K
94060 <1% 25 $1K
90681 <1% 68 $1K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 2,933 $1K
90696 <1% 69 $1K
86592 <1% 483 $1K
73610 <1% 791 $1K
76642 <1% 63 $1K
82746 <1% 129 $1K
84403 <1% 63 $1K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 12 $1K
0011A <1% 146 $1K
87205 <1% 722 $1K
85730 <1% 1,356 $1K
85652 <1% 828 $1K
73562 <1% 233 $992.04
87430 <1% 1,144 $962.11
87660 <1% 962 $939.02
84484 <1% 2,907 $930.46
88304 <1% 26 $911.93
87480 <1% 953 $903.10
85379 <1% 773 $900.17
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 126 $875.92
72110 <1% 117 $870.68
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 14 $847.40
87510 <1% 953 $813.33
90656 <1% 69 $789.63
86038 <1% 178 $726.90
73130 <1% 402 $697.41
87522 Neg quan hep c or qual rna <1% 15 $648.21
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 831 $622.58
73564 <1% 174 $603.12
71045 Radiologic examination, chest; single view <1% 1,335 $566.63
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 13 $537.22
97035 <1% 29 $531.42
93018 <1% 39 $495.18
86787 <1% 113 $472.52
86376 <1% 38 $441.81
82947 <1% 873 $420.93
0071A <1% 18 $400.00
82248 <1% 268 $389.01
86762 <1% 78 $381.04
83001 <1% 39 $371.60
86431 <1% 75 $344.08
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 57 $341.37
74018 <1% 140 $322.36
85018 <1% 332 $294.63
82784 <1% 37 $279.00
73502 <1% 88 $277.10
84703 <1% 822 $262.83
94726 <1% 12 $253.36
83605 <1% 1,214 $242.17
87040 <1% 422 $210.58
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 3,667 $186.08
93016 <1% 13 $184.95
86780 <1% 22 $178.64
84550 <1% 90 $159.42
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 108 $148.96
73110 <1% 124 $148.30
83002 <1% 12 $148.16
72050 <1% 28 $132.00
86800 <1% 13 $131.89
87081 <1% 109 $117.01
84146 <1% 13 $116.28
82962 <1% 366 $111.33
72070 <1% 12 $102.64
J7030 Infusion, normal saline solution , 1000 cc <1% 1,147 $101.60
90461 <1% 578 $95.00
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 245 $90.22
96375 Therapeutic injection; each additional sequential IV push <1% 2,851 $79.07
86364 <1% 12 $76.78
84100 <1% 19 $70.42
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 7,189 $48.80
80320 <1% 663 $48.00
83615 <1% 29 $46.91
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 295 $45.45
80306 <1% 126 $44.44
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 243 $44.26
J1040 Injection, methylprednisolone acetate, 80 mg <1% 600 $42.52
73560 <1% 12 $36.00
80143 <1% 184 $29.46
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,209 $27.19
82950 <1% 43 $22.87
82550 <1% 42 $20.32
J7120 Ringers lactate infusion, up to 1000 cc <1% 938 $17.23
90472 Immunization administration, each additional vaccine (list separately) <1% 205 $15.00
J2704 Injection, propofol, 10 mg <1% 1,053 $14.26
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 2,807 $12.38
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 202 $11.03
80329 <1% 193 $10.76
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 729 $10.35
80179 <1% 196 $8.56
J3010 Injection, fentanyl citrate, 0.1 mg <1% 911 $6.90
J2270 Injection, morphine sulfate, up to 10 mg <1% 793 $5.94
J3475 Injection, magnesium sulfate, per 500 mg <1% 84 $5.68
J1170 Injection, hydromorphone, up to 4 mg <1% 479 $2.75
J1010 Injection, methylprednisolone acetate, 1 mg <1% 35 $2.53
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 185 $1.92
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 893 $0.97
J0690 Injection, cefazolin sodium, 500 mg 0% 150 $0.00
87147 0% 27 $0.00
82077 0% 389 $0.00
96376 0% 170 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 14 $0.00
J2060 Injection, lorazepam, 2 mg 0% 143 $0.00
J7050 Infusion, normal saline solution, 250 cc 0% 20 $0.00
99024 0% 17 $0.00
S0028 Injection, famotidine, 20 mg 0% 28 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 191 $0.00
83721 0% 96 $0.00
J7510 Prednisolone oral, per 5 mg 0% 13 $0.00
G0444 Annual depression screening, 5 to 15 minutes 0% 76 $0.00
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 0% 75 $0.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 0% 46 $0.00
J2550 Injection, promethazine hcl, up to 50 mg 0% 12 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 27 $0.00
82948 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHICKEY, CHRIS (CFO)
Parent organizationALICE HYDE MEDICAL CENTER